Brief: Pharnext H1 Operating Loss Narrows To 7.8 Million Euros
Oct 15 (Reuters) - Pharnext SA PHARN.PA :
* PHARNEXT ANNOUNCES 2020 HALF-YEAR RESULTS
* H1 OPERATING LOSS EUR 7.8 MILLION VERSUS LOSS OF EUR 10.2
MILLION YEAR AGO
* H1 NET LOSS EUR 9.1 MILLION VERSUS LOSS OF EUR 12.3
MILLION
YEAR AGO
* H1 NET CASH FLOW EUR 7.4 MILLION VERSUS EUR 1.9 MILLION
YEAR
AGO
Source text for Eikon: ID:nEQbnRH8ha
Further company coverage: PHARN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Pharnext SCA
See all newsBrief: Pharnext Progresses On Charcot-Marie-Tooth Disease Study
Brief: Pharnext Reports Topline Results From Pivotal Phase III Clinical Trial Of PXT3003 In Charcot-Marie-Tooth Disease Type 1A
Brief: Pharnext Receives Offer Valuing Its Drug Candidate For Charcotmarie-Tooth Disease At Over Eur 500 Mln
Brief: Pharnext Appoints Dr Gilbert Wagener As Chief Medical Officer
Brief: Pharnext Reports Significant Progress In Search For Pharmaceutical Partners To Finance Its Development